NCT05130489View on ClinicalTrials.gov

CAR T Cell Therapy Related Cardiovascular Outcomes

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

March 1, 2023

Study Completion Date

May 1, 2023

Conditions
Cardiovascular DiseasesB-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma RefractoryB-cell Lymphoma RecurrentPrimary Mediastinal Large B-cell Lymphoma (PMBCL)Diffuse Large B Cell LymphomaCardiotoxicityCardiovascular Complication
Trial Locations (1)

Unknown

University College London Hospitals, London

All Listed Sponsors
lead

University College London Hospitals

OTHER

NCT05130489 - CAR T Cell Therapy Related Cardiovascular Outcomes | Biotech Hunter | Biotech Hunter